Oakstone The Brigham and Dana-Farber Board Review in Hematology and Oncology 2018

Oakstone The Brigham and Dana-Farber Board Review in Hematology and Oncology 2018

$10.00

+ Include: 58 videos + 2 pdfs, size: 9.87 GB

+ Target Audience: hematologists, oncologists

Description

+ Include: 58 videos + 2 pdfs, size: 9.87 GB

+ Target Audience: hematologists, oncologists

+ Sample video: contact me for sample video

+ Information:

This comprehensive CME program offers an in-depth, case-base review of the clinical essentials in hematology and oncology. Ideal for MOC.

Improve Patient Care in Hematology and Oncology

The Brigham and Dana-Farber Board Review in Hematology and Oncology will help improve clinical practice gaps in hematology and oncology derived from the American Board of Internal Medicine (ABIM) certification/recertification requirements. Relevant topics are addressed in case-based board review presentations. Improve patient care by learning to:

  • Perform differential diagnosis of complex hematologic and oncologic disorders
  • Identify and apply current therapeutic options for hematologic and oncologic disorders
  • Evaluate and interpret up-to-date literature relevant to hematology and oncology
  • Illustrate knowledge of pathophysiology of hematologic and oncologic disorders
  • Illustrate knowledge of pathophysiology as it applies to management of Hematology and Oncology disorders
  • Apply knowledge gained to the ABIM certification/recertification Hematology and Oncology examinations

Learning Objectives

Upon completion of this activity, the participant will be able to:

  • Apply current/recommended Hematology and Oncology guidelines in clinical practice
  • Perform differential diagnosis of complex clinical presentations related to Hematologic and Oncologic disorders
  • Identify/apply current therapeutic options for for specific Hematologic and Oncologic disorders
  • Evaluate and interpret up-to-date literature relevant to clinical practice in Hematology and Oncology
  • Illustrate knowledge of pathophysiology as it applies to management of Hematology and Oncology disorders
  • Apply knowledge gained to the ABIM certification/recertification Hematology and Oncology examinations

Intended Audience

The activity was planned for fellows/trainees, practicing Hematology and Oncology specialists (MDs), and other professional affiliates (internists with an interest in Hematology and Oncology) who are preparing to take ABIM Board Review or Recertification Examinations, or who seek CME activities to improve patient care in the areas of Hematology and Oncology Medicine.

Date Of Original Release: June 30, 2018

 

+ Topics:

1. Molecular Genetics of Cancer.mp4

2. Advances in Cancer Drug Development.mp4

3. Infections in Cancer Patients.mp4

4. Symptom Management in Patients with Cancer.mp4

5. Communication – The Key to Excellence in End-of-Life Care.mp4

6. Biology of Hematopoietic Stem Cell Transplantation.mp4

7. Biology of Acute Leukemia & Myelodysplastic Syndromes.mp4

8. Acute Leukemias.mp4

9. Myelodysplastic Syndrome.mp4

10. Chronic Myelogenous Leukemia.mp4

11. Myeloproliferative Syndromes.mp4

12. Multiple Myeloma.mp4

13. Waldenstrom’s Macroglobulemia, Amyloidosis.mp4

14. Low Grade Lymphomas.mp4

15. High Grade Lymphomas.mp4

16. Hodgkin’s Lymphoma.mp4

17. Diagnosis & Treatment of CLL & Related B Cell Malignancies.mp4

18. Head & Neck Cancer.mp4

19. Natural History, Screening, Surgery, Small Cell Lung Cancer.mp4

20. Non Small Cell Lung Cancer.mp4

21. Mesothelioma & Thymoma.mp4

22. Thyroid Cancer.mp4

23. Carcinoid & Pancreatic Neuroendocrine Tumors.mp4

24. Esophageal & Gastric Cancer.mp4

25. Pancreatic & Hepatobilary Cancer.mp4

26. Anal Cancers.mp4

27. Colorectal Cancers.mp4

28. Gastrointestinal Cancer – Genetic Syndromes.mp4

29. Germ Cell Tumor – Maximizing Cure While Minimizing the Burden of Therapy.mp4

30. Renal & Bladder Cancer.mp4

31. Prostate Cancer Part I – Overview & Management of Localized Disease.mp4

32. Prostate Cancer Part II – Management of Disseminated Prostate Cancer.mp4

33. Melanoma.mp4

34. Sarcomas & Gastrointestinal Stromal Tumors (GIST).mp4

35. Ovarian Cancer.mp4

36. Cervical & Endometrial Cancer.mp4

37. Neuro-oncology.mp4

38. Breast Cancer – Risk Factors, Genetics, Screening & Prevention.mp4

39. Breast Cancer – Advances in Staging, Prognosis, Surgery & Radiation & DCIS.mp4

40. Management for HER2-Positive & Triple Negative Breast Cancer.mp4

41. Breast Cancer Survivorship.mp4

42. Hematopoiesis & Cytokines.mp4

43. Acquired Bone Marrow Failure.mp4

44. Congenital Bone Marrow Failure.mp4

45. Hemophagocytic Syndromes & Related Immunodeficiencies.mp4

46. Anemia – An Overview.mp4

47. Iron Deficiency & Iron Overload.mp4

48. Immune Hemolytic Anemia.mp4

49. Non-immune Hemolytic Anemia.mp4

50. Sickle Cell Disease.mp4

51. Thalassemia & Other Hemoglobinopathies.mp4

52. Disorders of Neutrophils.mp4

53. Acquired Thrombocytopenias.mp4

54. Hemophilia.mp4

55. Von Willebrand Disease & Congenital Platelet Disorders.mp4

56. Congenital & Acquired Thrombophilia.mp4

57. New Oral Anticoagulants.mp4

58. Transfusion Medicine for the Clinician.mp4

Questions.pdf

Syllabus.pdf

Reviews

There are no reviews yet.

Be the first to review “Oakstone The Brigham and Dana-Farber Board Review in Hematology and Oncology 2018”

Your email address will not be published. Required fields are marked *

Related Products